Font DMV, del Valle GN, Sánchez BAH, Gallego GJ, Lashey OML

Language: Spanish
References: 16
Page:
PDF size: 114.22 Kb.

ABSTRACT

An observational, descriptive and prospective study was carried out to characterize 200 diabetic patients type 2, diagnosed with vascular complications and atherosclerosis risk, who were admitted in the Internal Medicine Service of "Dr. Juan Bruno Zayas Alfonso" Teaching General Hospital in Santiago de Cuba from June, 2010 to the same month of 2011. Among the most frequent complications there were: cardiovascular (29.5%), neuropathy (21.5%) and retinopathy (19.5%). The affected patients with 3 complications prevailed (40.5%), those who had a clinical course of 11- 15 years (38.0%); besides the hyperlipidemia (35.0%), hypertension (32.0%) and tabaquism (26.5%) as risk factors. It is concluded that with a multidisciplinary approach in the treatment and control of this disease, it is possible to improve the prognosis of the affected patients.

REFERENCES

1. Méndez Gómez H, Kessel Rodríguez JG, Díaz Borroto I, Hernández Morales C. Diabetes mellitus tipo 2 en el Municipio de Cárdenas. Matanzas. Matanzas: Centro de Atención al Paciente Diabético; 2008.

2. American Diabetes Association. Standards of medical care in diabetes-- 2007. Diabetes Care. 2007;30 (Suppl 1):s4-s41.

3. Clapés Hernández S, García Gómez D, Marquetti Hernández A, Martínez Bons O, Battes Lanz C, Castro T, et al. Influencia del tipo de diabetes y el tiempo de evolución de la enfermedad sobre indicadores de estrés oxidativo. Ciudad de la Habana: Centro nacional de Genética Médica; 2012.

4. Factores de riesgos cardiovasculares. Texas Heart Institute. [citado 8 Ene 2014]. Disponible en: http://www.texasheart.org/HIC/Topics_Esp/HSmart/riskspan.cfm

5. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009;32 (suppl 1):S62-S67.

6. Grupo de Trabajo de la Guía de Práctica Clínica sobre Cuidados Paliativos. Guía de Práctica Clínica sobre Cuidados Paliativos. Madrid: Plan Nacional para el SNS del MSC. Agencia de Evaluación de Tecnologías Sanitarias del País Vasco; 2008. Guías de Práctica Clínica en el SNS: OSTEBA Nº 2006/08. [citado citado 8 Ene 2014]. Disponible en: http://www.guiasalud.es/GPC/GPC_428 _Paliativos _Osteba_compl.pdf

7. Bolen S, Feldman L, Vassy J, Wilson L, Yeh HC, Marinopoulos S, et al. Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med. 2007;147(6):386-99.

8. American Diabetes Association. Standards of Medical Care for Patients with Diabetes Mellitus. Diabetes Care. 2003;26(Suppl 1):S33-49.

9. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycemia in type 2 diabetes: A Consensus Algorithm for the initiation and adjustment of therapy. A Consensus statement of the American Diabetes association and The European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193-203.

10. Superko HR. Advanced Lipoprotein Testing and Subfractionation are Clinically Useful. Circulation. 2009;119(17):2383-95.

11. Barter P, Gotto AM, La Rosa JC, Maroni J, Szarek M, Grundy SM, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J

12. Cardona F, Tinahones FJ. Relación entre la lipemia postpandrial y la aterosclerosis. De la práctica a la clínica. Nutr Clin Med. 2008;2:1-11. MEDISAN 2014; 18(12):1670

13. Spatz ES, Canavan ME, Desai MM. From here to JUPITER: identifying new patients for statin therapy using data from the 1999-2004 National Health and Nutrition Examination Survey. Circ Cardiovasc Qual Outcomes. 2009;2(1):41-8.

14. American Diabetes Association. Clinical Practice Recommendations 2009. Diabetes Care. 2009;32(Suppl 1):S29-S32.

15. O´Kane MJ, Bunting B, Copeland M, Coates VE. Efficacy of self monitoring of bood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ. 2008;336(7654):1174-7.

16. Nathan DM, Kuenen j, Borg J, Zheng H, Schoenfeld D, Heine RJ, et al. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473-8.